title: In vivo repair during G1 of DNA lesions eliciting sister chromatid exchanges induced by methylnitrosourea or ethylnitrosourea in BrdU substituted or unsubstituted DNA in murine salivary gland cells.
abstract: The difference in efficiency of methylnitrosourea (MNU) and ethylnitrosourea (ENU) to induce SCE in early or late G1 was determined in synchronized murine salivary gland cells in vivo, as a measure of the capacity of this tissue to repair the lesions involved in SCE formation during G1. The repair during G1 was determined by treating the cells in early or late G1. Treatment was in the first cycle (G1 before incorporation of 5-bromodeoxyuridine (BrdU)) or in G1 of the second cycle (after a single round of BrdU incorporation). It was observed that 50% of the lesions induced by MNU that elicit SCE are repaired during G1. BrdU incorporation into DNA increases the sensitivity of the cell to SCE induction by MNU nearly 40%; however under this circumstance a slightly lower SCE frequency was observed in the cells exposed to MNU at early G1, indicating that during G1 only few lesions are repaired. The ENU-induced DNA-lesions involved in SCE production are nearly 100% persistent along G1; besides, a slight but significantly higher SCE frequency was observed in cells exposed at early G1, suggesting the formation of SCE-inducing lesions during G1. BrdU incorporation to DNA sensitizes the cell to SCE induction by ENU, increasing the SCE frequency to nearly to a 40%, although these additional lesions involved in SCE induction seem to be susceptible to repair during G1.
authors.affiliation: Departamento de Genética Instituto Nacional de Investigaciones Nucleares, Mexico, D.F. Mexico.
authors.forename: F
authors.initials: F
authors.lastname: González-Beltrán
authors.forename: P
authors.initials: P
authors.lastname: Morales-Ramírez
mesh_terms: D000818:Animals; D001973:Bromodeoxyuridine / Q000494:pharmacology*; D002455:Cell Division / Q000187:drug effects; D004249:DNA Damage; D004260:DNA Repair; D004357:Drug Synergism; D005038:Ethylnitrosourea / Q000633:toxicity*; D016193:G1 Phase; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D008770:Methylnitrosourea / Q000633:toxicity*; D051379:Mice; D008807:Mice, Inbred BALB C; D009153:Mutagens / Q000633:toxicity*; D012469:Salivary Glands / Q000166:cytology*; D012854:Sister Chromatid Exchange / Q000187:drug effects / Q000235:genetics*
chemical_list: D009153:Mutagens; D008770:Methylnitrosourea; D001973:Bromodeoxyuridine; D007545:Isoproterenol; D005038:Ethylnitrosourea